A 15-year-old adolescent boy presents to his pediatrician for his scheduled follow-up after he was prescribed low-dose methylphenidate for treatment of attention-deficit/hyperactivity disorder 4 weeks ago. On follow-up, his mother reports mild improvement in his symptoms, but she also notes that his appetite has decreased significantly after starting the medication. This has led to a 1.6 kg (3.5 lb) weight loss over the last 4 weeks. His mother also reports that she no longer wants to continue the drug. Which of the following is the next drug of choice for pharmacological management of the condition?
Q672
A 58-year-old man presents to his primary care physician with a 3-week history of increasing pain in his legs and feet. Specifically, he says that he has been getting electric shock sensations that started in his feet, but have progressed up his leg. In addition, the pain is accompanied by numbness and tingling in his hands and feet bilaterally. His past medical history is significant for poorly controlled type 2 diabetes mellitus. Given these symptoms, his physician prescribes a new drug to help him cope with these symptoms. Which of the following is the mechanism of action for the medication that was most likely prescribed in this case?
Q673
A 69-year-old man with history of coronary artery disease necessitating angioplasty and stent placement presents to the ED due to fever, chills, and productive cough for one day. He is started on levofloxacin and admitted because of his comorbidity and observed tachypnea of 35 breaths per minute. He is continued on his home medications including aspirin, clopidogrel, metoprolol, and lisinopril. He cannot ambulate as frequently as he would like due to his immediate dependence on oxygen. What intervention should be provided for deep venous thrombosis prophylaxis in this patient while hospitalized?
Q674
A 64-year-old male presents to the emergency room with difficulty breathing. He recently returned to the USA following a trip to Singapore. He reports that he developed pleuritic chest pain, shortness of breath, and a cough. His temperature is 99°F (37.2°C), blood pressure is 140/85 mmHg, pulse is 110/min, and respirations are 24/min. A spiral CT reveals a pulmonary embolus in the right segmental pulmonary artery. Results from a complete blood count are all within normal limits. He is admitted and started on unfractionated heparin. Four days later, the patient develops unprovoked epistaxis. A complete blood count reveals the following:
Leukocyte count: 7,000/mm^3
Hemoglobin: 14 g/dl
Hematocrit: 44%
Platelet count 40,000/mm^3
What is the underlying pathogenesis of this patient’s condition?
Q675
A 52-year-old tow truck driver presents to the emergency room in the middle of the night complaining of sudden onset right ankle pain. He states that the pain came on suddenly and woke him up from sleep. It was so severe that he had to call an ambulance to bring him to the hospital since he was unable to drive. He has a history of hypertension and type 2 diabetes mellitus, for which he takes lisinopril and metformin. He has no other medical problems. The family history is notable for hypertension on his father's side. The vital signs include: blood pressure 126/86 mm Hg, heart rate 84/min, respiratory rate 14/min, and temperature 37.2°C (99.0°F). On physical exam, the patient's right ankle is swollen, erythematous, exquisitely painful, and warm to the touch. An arthrocentesis is performed and shows negatively birefringent crystals on polarized light. Which of the following is the best choice for treating this patient's pain?
Q676
A 34-year-old woman presents to the emergency department with sudden onset of painful vision loss in her left eye. The patient is otherwise healthy with a history only notable for a few emergency department presentations for numbness and tingling in her extremities with no clear etiology of her symptoms. Her temperature is 100°F (37.8°C), blood pressure is 122/83 mmHg, pulse is 100/min, respirations are 15/min, and oxygen saturation is 98% on room air. Examination of the patient's cranial nerves reveals an inability to adduct the left eye when the patient is asked to look right. Which of the following is the most appropriate treatment?
Q677
A 24-year-old woman in graduate school comes to the physician for recurrent headaches. The headaches are unilateral, throbbing, and usually preceded by blurring of vision. The symptoms last between 12 and 48 hours and are only relieved by lying down in a dark room. She has approximately two headaches per month and has missed several days of class because of the symptoms. Physical examination is unremarkable. The patient is prescribed an abortive therapy that acts by inducing cerebral vasoconstriction. Which of the following is the most likely mechanism of action of this drug?
Q678
A 38-year-old woman comes to the physician because of a 4-month history of crampy abdominal pain, recurrent watery diarrhea, and a 2.5-kg (5.5-lb) weight loss. Her husband has noticed that after meals, her face and neck sometimes become red, and she develops shortness of breath and starts wheezing. Examination shows a grade 3/6 systolic murmur heard best at the left lower sternal border. The abdomen is soft, and there is mild tenderness to palpation with no guarding or rebound. Without treatment, this patient is at greatest risk of developing which of the following conditions?
Q679
A 20-year-old man is found lying unconscious on the floor of his room by his roommate. The paramedics arrive at the site and find him unresponsive with cold, clammy extremities and constricted, non-reactive pupils. He smells of alcohol and his vital signs show the following: blood pressure 110/80 mm Hg, pulse 100/min, and respiratory rate 8/min. Intravenous access is established and dextrose is administered. The roommate suggests the possibility of drug abuse by the patient. He says he has seen the patient sniff a powdery substance, and he sees the patient inject himself often but has never confronted him about it. After the initial assessment, the patient is given medication and, within 5–10 minutes of administration, the patient regains consciousness and his breathing improves. He is alert and cooperative within the next few minutes. Which of the following drugs was given to this patient to help alleviate his symptoms?
Q680
A 65-year-old man presents to the physician with pain in his right calf over the last 3 months. He mentions that the pain typically occurs after he walks approximately 100 meters and subsides after resting for 5 minutes. His medical history is significant for hypercholesterolemia, ischemic heart disease, and bilateral knee osteoarthritis. His current daily medications include aspirin and simvastatin, which he has taken for the last 2 years. The physical examination reveals diminished popliteal artery pulses on the right side. Which of the following drugs is most likely to improve this patient's symptoms?
Autonomic/CV Drugs US Medical PG Practice Questions and MCQs
Question 671: A 15-year-old adolescent boy presents to his pediatrician for his scheduled follow-up after he was prescribed low-dose methylphenidate for treatment of attention-deficit/hyperactivity disorder 4 weeks ago. On follow-up, his mother reports mild improvement in his symptoms, but she also notes that his appetite has decreased significantly after starting the medication. This has led to a 1.6 kg (3.5 lb) weight loss over the last 4 weeks. His mother also reports that she no longer wants to continue the drug. Which of the following is the next drug of choice for pharmacological management of the condition?
A. Imipramine
B. Dextroamphetamine
C. Clonidine
D. Atomoxetine (Correct Answer)
E. Dexmethylphenidate
Explanation: ***Atomoxetine***
- This patient is experiencing significant **appetite suppression and weight loss** with methylphenidate, a common side effect of stimulants. Atomoxetine is a **non-stimulant** medication that can effectively treat ADHD without significantly affecting appetite.
- Atomoxetine is a **norepinephrine reuptake inhibitor** and is considered a second-line option for ADHD, especially when stimulants are not tolerated or are contraindicated.
*Imipramine*
- **Imipramine** is a **tricyclic antidepressant (TCA)** that can be used off-label for ADHD, but it is not typically considered a second-line drug of choice due to its potential for more significant side effects, including **cardiac abnormalities**.
- Its use for ADHD would generally be reserved for cases where other approved medications, including non-stimulants, have failed or are not tolerated.
*Dextroamphetamine*
- **Dextroamphetamine** is another **stimulant medication** with a mechanism of action similar to methylphenidate, and it carries the same risk profile for **appetite suppression and weight loss**.
- Switching to another stimulant like dextroamphetamine would likely lead to similar undesirable side effects and is therefore not the next drug of choice in this scenario.
*Clonidine*
- **Clonidine** is an **alpha-2 adrenergic agonist** that can be used to treat ADHD, particularly in cases with prominent **hyperactivity, impulsivity, or co-morbid tic disorders**.
- While it is a non-stimulant, it is generally considered a third-line option or an adjunct therapy, not typically the next monotherapy choice after a stimulant fails due to side effects.
*Dexmethylphenidate*
- **Dexmethylphenidate** is the **d-isomer of methylphenidate**, and it also works as a **stimulant**.
- It has a similar efficacy and side-effect profile to methylphenidate, including **appetite suppression and weight loss**, making it an inappropriate substitute in this situation.
Question 672: A 58-year-old man presents to his primary care physician with a 3-week history of increasing pain in his legs and feet. Specifically, he says that he has been getting electric shock sensations that started in his feet, but have progressed up his leg. In addition, the pain is accompanied by numbness and tingling in his hands and feet bilaterally. His past medical history is significant for poorly controlled type 2 diabetes mellitus. Given these symptoms, his physician prescribes a new drug to help him cope with these symptoms. Which of the following is the mechanism of action for the medication that was most likely prescribed in this case?
A. Serotonin norepinephrine reuptake inhibitor (Correct Answer)
B. Selective serotonin reuptake inhibitor
C. Binding to mu opioid receptors
D. Increased duration of GABA channel opening
E. Increased frequency of GABA channel opening
Explanation: ***Serotonin norepinephrine reuptake inhibitor***
- The patient's symptoms of **electric shock sensations** and **neuropathic pain** (numbness, tingling) in a diabetic patient suggest **diabetic neuropathy**.
- **SNRIs** such as Duloxetine and Venlafaxine are first-line agents for treating **neuropathic pain**, including diabetic neuropathy, by modulating pain pathways in the central nervous system.
*Selective serotonin reuptake inhibitor*
- While SSRIs can be used to treat depression, they are generally **not effective** for the treatment of **neuropathic pain**.
- Their primary mechanism is to increase serotonin levels, which is less impactful on neuropathic pain than the combined serotonin and norepinephrine effects of SNRIs.
*Binding to mu opioid receptors*
- Opioids work by binding to **mu opioid receptors** and are effective analgesics, but they are generally **reserved for severe pain** and are associated with significant side effects and risk of dependence.
- They are not considered a first-line treatment for chronic neuropathic pain due to concerns about addiction and limited long-term efficacy.
*Increased duration of GABA channel opening*
- This is the mechanism of action for **barbiturates**, which act by increasing the **duration of chloride channel opening** through GABA-A receptors.
- Barbiturates are potent sedatives and anticonvulsants but are **not used for neuropathic pain** due to their narrow therapeutic index and significant side effects.
*Increased frequency of GABA channel opening*
- This is the mechanism for **benzodiazepines**, which act on GABA-A receptors to increase the **frequency of chloride channel opening**.
- Benzodiazepines are primarily used as anxiolytics, sedatives, and anticonvulsants, and are **not indicated** for the treatment of neuropathic pain due to their sedative effects and lack of direct analgesic efficacy in this context.
Question 673: A 69-year-old man with history of coronary artery disease necessitating angioplasty and stent placement presents to the ED due to fever, chills, and productive cough for one day. He is started on levofloxacin and admitted because of his comorbidity and observed tachypnea of 35 breaths per minute. He is continued on his home medications including aspirin, clopidogrel, metoprolol, and lisinopril. He cannot ambulate as frequently as he would like due to his immediate dependence on oxygen. What intervention should be provided for deep venous thrombosis prophylaxis in this patient while hospitalized?
A. Aspirin and clopidogrel are sufficient
B. Warfarin
C. Aspirin is sufficient; hold clopidogrel
D. Clopidogrel is sufficient; hold aspirin
E. Low molecular weight heparin (Correct Answer)
Explanation: ***Low molecular weight heparin***
- This patient has multiple risk factors for DVT, including **immobility**, **acute illness (pneumonia)**, and **advanced age**. **Low molecular weight heparin (LMWH)** is the preferred pharmacological agent for DVT prophylaxis in hospitalized medical patients due to its efficacy and predictable pharmacokinetics.
- While the patient is on **antiplatelet agents**, these are not sufficient for DVT prophylaxis, which requires anticoagulation focusing on the clotting cascade, not platelet aggregation.
*Aspirin and clopidogrel are sufficient*
- **Aspirin** and **clopidogrel** are **antiplatelet agents** that prevent arterial thrombosis, primarily by inhibiting platelet aggregation.
- They do not adequately prevent **venous thromboembolism (VTE)**, which primarily involves fibrin clot formation and requires anticoagulants targeting the clotting cascade.
*Warfarin*
- **Warfarin** is an effective anticoagulant but has a **slow onset of action** (several days to therapeutic effect) and requires **frequent monitoring (INR)**.
- It is not suitable for **immediate DVT prophylaxis** in an acutely ill, hospitalized patient where rapid and predictable anticoagulation is needed.
*Aspirin is sufficient; hold clopidogrel*
- As an **antiplatelet agent**, **aspirin** alone is insufficient for DVT prophylaxis, which mechanisms differ from arterial thrombosis.
- Holding **clopidogrel** in a patient with a recent coronary stent could increase the risk of **stent thrombosis**, which is a significant and potentially life-threatening complication.
*Clopidogrel is sufficient; hold aspirin*
- Similar to aspirin, **clopidogrel** is an antiplatelet agent and therefore **insufficient for DVT prophylaxis** alone.
- Holding **aspirin** in a patient with a recent coronary stent could also increase the risk of **stent thrombosis**, which is critically important to prevent.
Question 674: A 64-year-old male presents to the emergency room with difficulty breathing. He recently returned to the USA following a trip to Singapore. He reports that he developed pleuritic chest pain, shortness of breath, and a cough. His temperature is 99°F (37.2°C), blood pressure is 140/85 mmHg, pulse is 110/min, and respirations are 24/min. A spiral CT reveals a pulmonary embolus in the right segmental pulmonary artery. Results from a complete blood count are all within normal limits. He is admitted and started on unfractionated heparin. Four days later, the patient develops unprovoked epistaxis. A complete blood count reveals the following:
Leukocyte count: 7,000/mm^3
Hemoglobin: 14 g/dl
Hematocrit: 44%
Platelet count 40,000/mm^3
What is the underlying pathogenesis of this patient’s condition?
A. ADAMTS13 deficiency
B. Loss of vitamin K-dependent clotting factors
C. Autoantibodies directed against platelet factor 4 (Correct Answer)
D. Medication-mediated platelet aggregation
E. Autoantibodies directed against GPIIb/IIIa
Explanation: ***Autoantibodies directed against platelet factor 4***
- The patient developed **thrombocytopenia** (platelet count 40,000/mm^3) and bleeding (epistaxis) after starting **unfractionated heparin**, which is highly suggestive of **heparin-induced thrombocytopenia (HIT)**.
- HIT is characterized by the formation of **autoantibodies against the heparin-platelet factor 4 (PF4) complex**, leading to platelet activation and consumption, paradoxically increasing the risk of both bleeding and thrombosis.
*ADAMTS13 deficiency*
- **ADAMTS13 deficiency** causes **thrombotic thrombocytopenic purpura (TTP)**, characterized by microangiopathic hemolytic anemia, acute kidney injury, neurologic symptoms, fever, and severe thrombocytopenia.
- While TTP presents with thrombocytopenia, it is not typically associated with heparin use and lacks the specific clinical context of HIT.
*Loss of vitamin K-dependent clotting factors*
- **Loss of vitamin K-dependent clotting factors** (factors II, VII, IX, X, and proteins C and S) typically occurs with **warfarin overdose** or severe vitamin K deficiency, leading to prolongation of PT/INR and increased bleeding risk.
- This condition primarily affects coagulation factor synthesis rather than platelet count, which would not explain the observed thrombocytopenia.
*Medication-mediated platelet aggregation*
- **Medication-mediated platelet aggregation** can occur with certain drugs like **NSAIDs** or **COX-2 inhibitors**, leading to reduced platelet function and increased bleeding.
- This mechanism inhibits platelet function but does not cause the severe thrombocytopenia seen in this patient, which is characteristic of HIT.
*Autoantibodies directed against GPIIb/IIIa*
- **Autoantibodies directed against GPIIb/IIIa** cause **immune thrombocytopenia (ITP)**, characterized by isolated thrombocytopenia, often without an inciting drug like heparin.
- While ITP presents with low platelet counts, the specific trigger of heparin in this patient points away from primary ITP towards drug-induced thrombocytopenia.
Question 675: A 52-year-old tow truck driver presents to the emergency room in the middle of the night complaining of sudden onset right ankle pain. He states that the pain came on suddenly and woke him up from sleep. It was so severe that he had to call an ambulance to bring him to the hospital since he was unable to drive. He has a history of hypertension and type 2 diabetes mellitus, for which he takes lisinopril and metformin. He has no other medical problems. The family history is notable for hypertension on his father's side. The vital signs include: blood pressure 126/86 mm Hg, heart rate 84/min, respiratory rate 14/min, and temperature 37.2°C (99.0°F). On physical exam, the patient's right ankle is swollen, erythematous, exquisitely painful, and warm to the touch. An arthrocentesis is performed and shows negatively birefringent crystals on polarized light. Which of the following is the best choice for treating this patient's pain?
A. Administer colchicine (Correct Answer)
B. Administer febuxostat
C. Administer indomethacin
D. Administer allopurinol
E. Administer probenecid
Explanation: ***Administer colchicine***
- The patient's presentation with **sudden onset, severe right ankle pain**, **swelling**, **erythema**, and **warmth** strongly suggests an acute gout attack, confirmed by **negatively birefringent crystals** (monosodium urate) on arthrocentesis.
- **Colchicine** is a **first-line treatment for acute gout** and is particularly appropriate for this patient given his comorbidities (**type 2 diabetes** and **hypertension**) and concomitant use of **lisinopril** (ACE inhibitor).
- Colchicine is **most effective when started within 36 hours** of symptom onset and has a **favorable safety profile** compared to NSAIDs in patients with cardiovascular and renal risk factors.
- It works by inhibiting microtubule polymerization, thereby reducing neutrophil migration and inflammatory response in the affected joint.
*Administer indomethacin*
- **Indomethacin** and other **NSAIDs** are also first-line options for acute gout in healthy individuals due to their potent anti-inflammatory effects.
- However, NSAIDs are **relatively contraindicated** in this patient because they can:
- **Worsen renal function**, especially concerning in patients taking ACE inhibitors like lisinopril
- Cause **fluid retention** and exacerbate hypertension
- Increase **cardiovascular risk** in patients with diabetes
- While effective for gout, NSAIDs are not the best choice given this patient's specific comorbidities.
*Administer febuxostat*
- **Febuxostat** is a **xanthine oxidase inhibitor** used for the prophylactic management of chronic gout by lowering uric acid levels.
- It is **not indicated for treating acute gout attacks** as it does not provide immediate pain relief and can worsen an acute flare if initiated during the attack.
- Febuxostat should be started only after the acute attack has resolved.
*Administer allopurinol*
- **Allopurinol** is another **xanthine oxidase inhibitor** used for the long-term management of chronic gout by reducing uric acid production.
- It is **contraindicated during an acute gout flare** because initiating or changing the dose can precipitate or prolong the attack due to rapid changes in serum uric acid levels.
- Like febuxostat, it should be started after the acute episode resolves.
*Administer probenecid*
- **Probenecid** is a **uricosuric agent** that increases renal uric acid excretion and is used for the long-term management of chronic gout in patients who underexcrete uric acid.
- It is **not effective for acute gout attacks** and should not be initiated during a flare as it can worsen symptoms.
- Probenecid is also contraindicated in patients with renal impairment.
Question 676: A 34-year-old woman presents to the emergency department with sudden onset of painful vision loss in her left eye. The patient is otherwise healthy with a history only notable for a few emergency department presentations for numbness and tingling in her extremities with no clear etiology of her symptoms. Her temperature is 100°F (37.8°C), blood pressure is 122/83 mmHg, pulse is 100/min, respirations are 15/min, and oxygen saturation is 98% on room air. Examination of the patient's cranial nerves reveals an inability to adduct the left eye when the patient is asked to look right. Which of the following is the most appropriate treatment?
A. Methylprednisolone (Correct Answer)
B. Rituximab
C. Glatiramer acetate
D. Estriol
E. Interferon-beta
Explanation: ***Methylprednisolone***
- This patient presents with symptoms highly suggestive of an acute **multiple sclerosis (MS) exacerbation**, including painful vision loss (optic neuritis), prior neurological symptoms (numbness and tingling), and internuclear ophthalmoplegia (inability to adduct one eye while the other abducts, indicating a lesion in the **medial longitudinal fasciculus**).
- High-dose intravenous **methylprednisolone** is the first-line treatment for acute MS relapses to reduce inflammation and shorten the duration of the exacerbation.
*Rituximab*
- **Rituximab** is an anti-CD20 monoclonal antibody used as a disease-modifying therapy for MS, particularly for **relapsing-remitting MS (RRMS)** and **primary progressive MS (PPMS)**.
- It is not used for the acute treatment of an MS exacerbation, but rather for long-term disease management.
*Glatiramer acetate*
- **Glatiramer acetate** is an immunomodulatory drug used as a disease-modifying therapy for **relapsing forms of MS**.
- It helps reduce the frequency of relapses and slow disease progression but is not indicated for the immediate treatment of an acute flare-up.
*Estriol*
- **Estriol** is a weak estrogen that has shown some promise in clinical trials for MS, particularly in reducing relapse rates during pregnancy and in postpartum women.
- However, it is **not an approved treatment** for MS and certainly not for an acute exacerbation.
*Interferon-beta*
- **Interferon-beta** is a common **disease-modifying therapy** for relapsing forms of MS, reducing the frequency and severity of relapses.
- Like glatiramer acetate and rituximab, it is used for chronic management rather than for treating an acute MS exacerbation.
Question 677: A 24-year-old woman in graduate school comes to the physician for recurrent headaches. The headaches are unilateral, throbbing, and usually preceded by blurring of vision. The symptoms last between 12 and 48 hours and are only relieved by lying down in a dark room. She has approximately two headaches per month and has missed several days of class because of the symptoms. Physical examination is unremarkable. The patient is prescribed an abortive therapy that acts by inducing cerebral vasoconstriction. Which of the following is the most likely mechanism of action of this drug?
A. Activation of 5-HT1 receptors (Correct Answer)
B. Inhibition of 5-HT and NE reuptake
C. Inhibition of β1- and β2-adrenergic receptors
D. Inhibition of voltage-dependent Na+ channels
E. Inactivation of GABA degradation
Explanation: ***Activation of 5-HT1 receptors***
- The patient's symptoms are consistent with **migraine headaches**, which are characterized by unilateral, throbbing pain, visual aura (blurring of vision), and relief by lying down in a dark room.
- Triptan medications, commonly used as **abortive therapy** for migraines, act as **5-HT1B/1D receptor agonists**, leading to **cerebral vasoconstriction** and inhibition of neuropeptide release.
*Inhibition of 5-HT and NE reuptake*
- This mechanism describes the action of **serotonin-norepinephrine reuptake inhibitors (SNRIs)**, which are primarily used as antidepressants and sometimes for neuropathic pain.
- While some antidepressants can be used for **migraine prophylaxis**, they do not act as acute abortive therapy to induce cerebral vasoconstriction.
*Inhibition of β1- and β2-adrenergic receptors*
- This mechanism describes the action of **beta-blockers**, which are commonly used for conditions like hypertension, angina pectoris, and sometimes as **migraine prophylaxis**.
- Beta-blockers reduce heart rate and blood pressure and do not induce acute cerebral vasoconstriction for migraine abortion.
*Inhibition of voltage-dependent Na+ channels*
- This mechanism describes the action of certain **antiepileptic drugs** (e.g., carbamazepine, lamotrigine) and **local anesthetics**, which are used to stabilize neuronal membranes and prevent excessive firing.
- Some antiepileptics (e.g., topiramate, valproate) can be used for **migraine prophylaxis**, but they do not mediate acute vasoconstriction for abortive treatment.
*Inactivation of GABA degradation*
- This mechanism describes the action of drugs like **valproic acid** or **vigabatrin**, which increase GABA levels in the brain to inhibit neuronal activity, commonly used for seizure disorders.
- While valproic acid can be used for **migraine prophylaxis**, it does not achieve acute migraine relief through cerebral vasoconstriction.
Question 678: A 38-year-old woman comes to the physician because of a 4-month history of crampy abdominal pain, recurrent watery diarrhea, and a 2.5-kg (5.5-lb) weight loss. Her husband has noticed that after meals, her face and neck sometimes become red, and she develops shortness of breath and starts wheezing. Examination shows a grade 3/6 systolic murmur heard best at the left lower sternal border. The abdomen is soft, and there is mild tenderness to palpation with no guarding or rebound. Without treatment, this patient is at greatest risk of developing which of the following conditions?
A. T-cell lymphoma
B. Achlorhydria
C. Pigmented dermatitis (Correct Answer)
D. Megaloblastic anemia
E. Laryngeal edema
Explanation: ***Pigmented dermatitis***
- This patient has **carcinoid syndrome** (flushing, diarrhea, wheezing, heart murmur from right-sided valvular disease).
- Without treatment, patients are at risk of developing **pellagra** (pigmented dermatitis, diarrhea, dementia).
- **Pellagra** results from **niacin (vitamin B3) deficiency** because tryptophan is diverted away from niacin synthesis to produce excessive **serotonin** by the carcinoid tumor.
- The classic triad of pellagra is the "3 Ds": **Dermatitis** (photosensitive, pigmented skin changes), **Diarrhea**, and **Dementia**.
*T-cell lymphoma*
- There is **no established association** between carcinoid syndrome and T-cell lymphoma.
- While neuroendocrine tumors can metastasize, they do not predispose to lymphoid malignancies.
*Achlorhydria*
- **Achlorhydria** can be associated with **gastric type 1 carcinoid tumors** that occur in the setting of chronic atrophic gastritis and pernicious anemia.
- However, this patient has **metastatic carcinoid syndrome** (requires liver metastases for systemic symptoms), not a localized gastric carcinoid.
- Achlorhydria would precede the gastric carcinoid, not develop as a complication of systemic carcinoid syndrome.
*Laryngeal edema*
- **Laryngeal edema** is not a recognized complication of carcinoid syndrome.
- While carcinoid crisis can cause severe bronchospasm and flushing, laryngeal edema is more typical of **angioedema** from ACE inhibitor use or C1 esterase inhibitor deficiency.
*Megaloblastic anemia*
- **Megaloblastic anemia** results from **vitamin B12 or folate deficiency**.
- This is not a typical complication of carcinoid syndrome, which primarily affects tryptophan/niacin metabolism, not B12 or folate.
Question 679: A 20-year-old man is found lying unconscious on the floor of his room by his roommate. The paramedics arrive at the site and find him unresponsive with cold, clammy extremities and constricted, non-reactive pupils. He smells of alcohol and his vital signs show the following: blood pressure 110/80 mm Hg, pulse 100/min, and respiratory rate 8/min. Intravenous access is established and dextrose is administered. The roommate suggests the possibility of drug abuse by the patient. He says he has seen the patient sniff a powdery substance, and he sees the patient inject himself often but has never confronted him about it. After the initial assessment, the patient is given medication and, within 5–10 minutes of administration, the patient regains consciousness and his breathing improves. He is alert and cooperative within the next few minutes. Which of the following drugs was given to this patient to help alleviate his symptoms?
A. Ethanol
B. Naloxone (Correct Answer)
C. Dextrose
D. Atropine
E. Methadone
Explanation: ***Naloxone***
- The patient's presentation with **unconsciousness**, **respiratory depression** (8 breaths/min), **constricted pupils**, and rapid improvement after medication strongly suggests an **opioid overdose**.
- **Naloxone** is an **opioid antagonist** that rapidly reverses the effects of opioid overdose by competing for opioid receptors.
*Ethanol*
- While the patient smells of alcohol, **ethanol** intoxication typically presents with a different constellation of symptoms and does not usually cause such profound and rapid respiratory depression with pinpoint pupils that are instantly reversible by naloxone.
- Furthermore, administering more ethanol would worsen his condition, not improve it.
*Dextrose*
- **Dextrose** was already administered and did not lead to improvement, ruling out **hypoglycemia** as the primary cause of unconsciousness.
- While hypoglycemia can cause unconsciousness, it does not typically lead to **respiratory depression** or **pinpoint pupils**.
*Atropine*
- **Atropine** is an **anticholinergic** agent used to treat bradycardia or organophosphate poisoning, which would present with different symptoms such as excessive salivation, lacrimation, and bronchorrhea.
- It would worsen constricted pupils rather than being beneficial in this scenario because it causes pupillary dilation (mydriasis).
*Methadone*
- **Methadone** is a **long-acting opioid agonist** used for opioid addiction treatment or severe pain. Administering methadone to someone suffering from an opioid overdose would worsen their condition due to its opioid effects.
- It has a slow onset of action and is not used as an acute rescue medication for overdose.
Question 680: A 65-year-old man presents to the physician with pain in his right calf over the last 3 months. He mentions that the pain typically occurs after he walks approximately 100 meters and subsides after resting for 5 minutes. His medical history is significant for hypercholesterolemia, ischemic heart disease, and bilateral knee osteoarthritis. His current daily medications include aspirin and simvastatin, which he has taken for the last 2 years. The physical examination reveals diminished popliteal artery pulses on the right side. Which of the following drugs is most likely to improve this patient's symptoms?
A. Cilostazol (Correct Answer)
B. Acetaminophen
C. Isosorbide dinitrate
D. Ranolazine
E. Amlodipine
Explanation: ***Cilostazol***
- This patient presents with symptoms highly suggestive of **peripheral artery disease (PAD)**, characterized by **intermittent claudication** (calf pain with exertion, relieved by rest) and diminished peripheral pulses, exacerbated by risk factors like hypercholesterolemia and ischemic heart disease.
- **Cilostazol** is a **phosphodiesterase-3 inhibitor** that increases **cAMP** in platelets and vascular smooth muscle, leading to **vasodilation** and **inhibition of platelet aggregation**, effectively improving claudication symptoms and increasing walking distance in patients with PAD.
*Acetaminophen*
- **Acetaminophen** is an **analgesic** and **antipyretic** but does not address the underlying pathophysiology of peripheral artery disease or directly improve blood flow.
- While it could help with pain management, it would not improve the patient's **walking distance** or the fundamental issue of **ischemia**.
*Isosorbide dinitrate*
- **Isosorbide dinitrate** is a **nitrate** primarily used to treat **angina pectoris** by causing **venodilation** and reducing cardiac preload, and arterial dilation at higher doses.
- It would not specifically address the **intermittent claudication** caused by atherosclerotic peripheral artery disease in the lower extremities.
*Ranolazine*
- **Ranolazine** is an anti-anginal agent that **inhibits the late sodium current** in cardiac myocytes, improving myocardial oxygen supply/demand balance.
- It is used for **chronic stable angina** but does not have a role in treating peripheral artery disease or improving symptoms of claudication.
*Amlodipine*
- **Amlodipine** is a **dihydropyridine calcium channel blocker** used primarily for **hypertension** and **angina**.
- While it causes vasodilation, it does not specifically improve the symptoms of **intermittent claudication** in PAD and is not a first-line treatment for this condition.